Prosecution Insights
Last updated: August 17, 2026
Application No. 17/559,097

COMPOSITION INCLUDING REFRIGERANT, USE THEREOF, REFRIGERATOR HAVING SAME, AND METHOD FOR OPERATING SAID REFRIGERATOR

Final Rejection §103
Filed
Dec 22, 2021
Priority
Jun 26, 2019 — JP 2019-118916 +1 more
Examiner
CAI, JIAJIA JANIE
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Daikin Industries Ltd.
OA Round
4 (Final)
27%
Grant Probability
At Risk
5-6
OA Rounds
0m
Est. Remaining
46%
With Interview

Examiner Intelligence

Grants only 27% of cases
27%
Career Allowance Rate
13 granted / 48 resolved
-37.9% vs TC avg
Strong +19% interview lift
Without
With
+19.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
37 currently pending
Career history
98
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
60.1%
+20.1% vs TC avg
§102
10.3%
-29.7% vs TC avg
§112
19.5%
-20.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 48 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This action is responsive to Applicant's remarks/declaration filed 06/08/2026. Claims 1 and 3-8 are currently pending and under examination. The rejection of claims 1, 3, and 5-8 under 35 U.S.C. 103 as being unpatentable over Hashimoto (JP 2015-229767 A) in view of Itano (WO 2017/171090 A1, see US 2020/0308463 A1) is maintained in the view of the above remarks/declaration. The rejection of claim 4 under 35 U.S.C. 103 as being unpatentable over Hashimoto (JP 2015-229767 A) in view of Itano (WO 2017/171090 A1, see US 2020/0308463 A1), and further in view of Fukushima (US 2016/0355719 A1) is maintained in the view of the above remarks/declaration. The rationale of record remains the same. See pages 3 to 12 of the Non-Final Office action filed 01/09/2026. The declaration under 37 CFR 1.132 filed 06/08/2026 is insufficient to overcome the rejections as set forth in the Non-Final Office action filed 01/09/2026 because of the following reasons. Response to Arguments Applicant's arguments filed 06/08/2026 have been fully considered but they are not persuasive. 1. Applicant argues that Hashimoto fails to suggest a selection of HFO-1132a from the five first compounds; a person skilled in the art would not be motivated to obtain the composition according to Claim 1 of the present application in view of Hashimoto's teachings (Remarks, p. 10). In response, Applicant’s arguments are not persuasive. Hashimoto teaches (para [0018]) that a working fluid comprises (E)-HFO-1132, and a first compound, wherein the first compound is at least one selected from the group consisting of HFO-1132a, HFO-1141, HFC-161, (Z)-HFO-1132 and ethylene. Therefore, a person of skill in the art reading Hashimoto would still “at once envisage” HFO-1132a from the five compounds, because there are only five compounds in the Markush group. Please note, a reference disclosure can anticipate a claim when the reference describes the limitations but "'d[oes] not expressly spell out' the limitations as arranged or combined as in the claim, if a person of skill in the art, reading the reference, would ‘at once envisage’ the claimed arrangement or combination.” Kennametal, Inc. v. Ingersoll Cutting Tool Co., 780 F.3d 1376, 1381, 114 USPQ2d 1250, 1254 (Fed. Cir. 2015) (quoting In re Petering, 301 F.2d 676, 681(CCPA 1962)). In Kennametal, the challenged claim was to a cutting tool requiring a ruthenium binding agent with a physical vapor deposition (PVD) coating. The reference described all the elements of the claimed coated cutting tool but did not explicitly disclose the specific combination of ruthenium binding agent with a PVD coating. However, the reference disclosed that ruthenium was one of five specified binding agents and PVD was one of three suitable coating techniques. The Federal Circuit stated that the reference’s “express ‘contemplat[ion]’ of PVD coatings provided sufficient evidence that a reasonable mind could find that a person of skill in the art… would immediately envisage applying a PVD coating. Thus, substantial evidence supports the Board's conclusion that [the reference] effectively teaches 15 combinations, of which one anticipates pending claim 1. Though it is true that there is no evidence in [the reference] of ‘actual performance’ of combining the ruthenium binder and PVD coatings, this is not required.” Kennametal, 780 F.3d at 1383, 114 USPQ2d at 1255 (citations omitted). See also Nidec Motor Corp. v. Zhongshan Broad Ocean Motor Co., 851 F.3d 1270, 1274, 122 USPQ2d 1116, 1120 (Fed. Cir. 2017). See MPEP 2131.02. III. Hashimoto also teaches that the working fluid further comprises HFC-32 and HFO-1234yf (para [0024], [0031]). Hashimoto further teaches that by setting the ratio of each component within the above-mentioned range, a working fluid will have sufficient cycle performance and less impact on global warming (para [0032]). Therefore, it would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to make a working fluid comprising (E)-HFO-1132, and a first compound such as HFO-1132a, further comprising HFC-32 and HFO-1234yf as taught by Hashimoto, wherein (E)-HFO-1132 is in an amount of 20 mass% or more and less than 70 mass%, HFO-1132a is in an amount of less than 1.5 mass%, HFC-32 is in an amount of 30 mass% or more and 75 mass% or less, and HFO-1234yf is in an amount of 5 mass % or more and 50 mass % or less based on the total amount of the working fluid. For doing so, the working fluid will have sufficient cycle performance and less impact on global warming with a reasonable expectation of success, because by setting the ratio of each component within the above-mentioned range, a working fluid will have sufficient cycle performance and less impact on global warming as art recognized. The Examiner has carefully plotted the working fluid of Hashimoto comprising (E)-HFO-1132 in an amount of 20 mass% or more and less than 70 mass%, HFO-1132a in an amount of less than 1.5 mass%, HFC-32 in an amount of 30 mass% or more and 75 mass% or less, and HFO-1234yf in an amount of 5 mass % or more and 50 mass % or less, against the claimed range of a figure surrounded by straight lines OC, CD, DE, EJ, JF, and FO when a is 37.8 in a ternary diagram: PNG media_image1.png 1399 1727 media_image1.png Greyscale In the ternary diagram above, the figure with a solid black color is the overlapping area. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to have selected the overlapping portion of the ranges disclosed by the reference because selection of overlapping portion of ranges has been held to be a prima facie case of obviousness. See MPEP § 2144.05.I. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art. 2. Applicant argues that as shown in the Declaration filed 06/08/2026, selecting HFO-1132a results in the highest refrigerating capacity, and that this technical effect is unexpected, and it cannot be inferred from the disclosure of Hashimoto; the cycle performance of the mixed refrigerant was only significantly improved when HFO-1132a was present as an additional compound, even in a trace amounts; when an additional refrigerant other than HFO-1132a was contained at 0.5 to 1.5 mass%, the cycle performance deteriorated under all conditions compared to Ex. 1, which did not contain an additional refrigerant; when HFO-1141 was contained at 3.0 mass% or more as an additional refrigerant, the cycle performance of the mixed refrigerant was improved compared to Ex. 1, but to a smaller degree compared to HFO-1132a (Table D); when Z-HFO-1132 and R161 were contained, the cycle performance deteriorated even when the content of the additional refrigerant was increased to 10 mass% (Tables B and C) (Remarks, pp. 10-11; Declaration, Tables A-D, pp. 6-7). In response, Applicant’s arguments are not persuasive. Hashimoto teaches (para [0018]) that a working fluid comprises (E)-HFO-1132, and a first compound, wherein the first compound is at least one selected from the group consisting of HFO-1132a, HFO-1141, HFC-161, (Z)-HFO-1132 and ethylene. Hashimoto also teaches (para [0023]) that when the total content of the first compounds is less than 1.5 mass % based on the total amount of the working fluid, a working fluid having sufficiently excellent cycle performance can be obtained. In response to Applicant's argument that the cycle performance of the mixed refrigerant was only significantly improved when HFO-1132a was present as an additional compound, even in a trace amounts, the fact that the inventor has recognized another advantage which would flow naturally from following the suggestion of the prior art cannot be the basis for patentability when the differences would otherwise be obvious. See Ex parte Obiaya, 227 USPQ 58, 60 (Bd. Pat. App. & Inter. 1985) (The prior art taught combustion fluid analyzers which used labyrinth heaters to maintain the samples at a uniform temperature. Although appellant showed that an unexpectedly shorter response time was obtained when a labyrinth heater was employed, the Board held this advantage would flow naturally from following the suggestion of the prior art.). See also Lantech Inc. v. Kaufman Co. of Ohio Inc., 878 F.2d 1446, 12 USPQ2d 1076, 1077 (Fed. Cir. 1989), cert. denied, 493 U.S. 1058 (1990) (unpublished — not citable as precedent) ("The recitation of an additional advantage associated with doing what the prior art suggests does not lend patentability to an otherwise unpatentable invention."). See MPEP 2145.II. 3. Applicant argues that the Declaration filed 06/08/2026 demonstrates that the working fluid disclosed in Hashimoto does not have a high refrigerating capacity comparable to that of R410A (p. 10). In response, Applicant’s argument is not persuasive. The instant invention discloses that R410A is a mixed refrigerant of HFC-32 and HFC-125 in a mass ratio of 1:1 (instant US [0002], [0353]). Tables A-D of the Declaration filed 06/08/2026 do not compare the working fluid disclosed in Hashimoto with R410A. Therefore, the Office does not understand how Applicant gets the conclusion that the Declaration filed 06/08/2026 demonstrates that the working fluid disclosed in Hashimoto does not have a high refrigerating capacity comparable to that of R410A. 4. Applicant argues that the Examples in Table 3 of Hashimoto show that the refrigerating capacity decreases regardless of which compound is selected as the first compound, see below: PNG media_image2.png 200 400 media_image2.png Greyscale ; based on such Examples, a person skilled in the art would not have considered deliberately selecting and adding HFO-1132a, which is an impurity and the first compound, to the mixed refrigerant (Declaration, p. 7). In response, Applicant’s argument is not persuasive. Hashimoto teaches (para [0018]) that a working fluid comprises (E)-HFO-1132, and a first compound, wherein the first compound is at least one selected from the group consisting of HFO-1132a, HFO-1141, HFC-161, (Z)-HFO-1132 and ethylene. Hashimoto also teaches (para [0023]) that when the total content of the first compounds is less than 1.5 mass % based on the total amount of the working fluid, a working fluid having sufficiently excellent cycle performance can be obtained; the total content of the first compounds is preferably 4 ppm or more (i.e. 0.0004 mass %) based on the total amount of the working fluid. Furthermore, the Examples in Table 3 of Hashimoto show that when the first compound is contained at 0.1 wt.%, the evaluation is PNG media_image3.png 200 400 media_image3.png Greyscale , which means the refrigerating capacity is excellent. Therefore, a person skilled in the art would have considered adding a first compound such as HFO-1132a in the working fluid as taught by Hashimoto, because when the total content of the first compounds is 4 ppm or more and less than 1.5 mass % based on the total amount of the working fluid, a working fluid having sufficiently excellent cycle performance can be obtained as recognized by Hashimoto. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIAJIA JANIE CAI whose telephone number is 571-270-0951. The examiner can normally be reached Monday-Friday 8:30 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner' s supervisor, Angela Brown-Pettigrew can be reached on 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JIAJIA JANIE CAI/Examiner, Art Unit 1761 /ANGELA C BROWN-PETTIGREW/Supervisory Patent Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Show 3 earlier events
Aug 05, 2025
Final Rejection mailed — §103
Nov 05, 2025
Request for Continued Examination
Nov 05, 2025
Response after Non-Final Action
Nov 06, 2025
Response after Non-Final Action
Jan 09, 2026
Non-Final Rejection mailed — §103
Jun 08, 2026
Response Filed
Jun 08, 2026
Response after Non-Final Action
Jul 16, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679933
POLYORGANOSILOXANE AND THERMALLY CONDUCTIVE SILICONE COMPOSITION THEREOF
4y 8m to grant Granted Jul 14, 2026
Patent 12623984
AZEOTROPIC OR AZEOTROPE-LIKE COMPOSITION CONTAINING TRIFLUOROETHYLENE
4y 7m to grant Granted May 12, 2026
Patent 12600893
LIGHT-HEAT ENERGY CONVERSION AND HEAT ENERGY STORAGE SHAPE-STABILIZED PHASE-CHANGE COMPOSITE MATERIAL AND PRODUCTION METHOD THEREFOR
4y 8m to grant Granted Apr 14, 2026
Patent 12534654
COMPOSITION INCLUDING 1,1,2-TRIFLUOROETHANE (HFC-143)
4y 4m to grant Granted Jan 27, 2026
Patent 12531242
DOPED LITHIUM IRON PHOSPHATE ENCAPSULATED IN LIGAND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
2y 2m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
27%
Grant Probability
46%
With Interview (+19.4%)
3y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 48 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month